These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 15817068

  • 1. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
    Rajpura KB, Patel PS, Chawda JG, Shah RM.
    J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
    [Abstract] [Full Text] [Related]

  • 2. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H, Kumar CA.
    Cancer Biomark; 2005 May; 10(1):43-9. PubMed ID: 22297551
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
    Raval GN, Patel DD, Parekh LJ, Patel JB, Shah MH, Patel PS.
    Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
    [Abstract] [Full Text] [Related]

  • 4. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
    Patel PS, Shah MH, Jha FP, Raval GN, Rawal RM, Patel MM, Patel JB, Patel DD.
    Indian J Cancer; 2004 May; 41(1):25-31. PubMed ID: 15105576
    [Abstract] [Full Text] [Related]

  • 5. Significance of serum sialoglycoproteins in patients with lung cancer.
    Patel PS, Baxi BR, Balar DB.
    Neoplasma; 1989 May; 36(1):53-9. PubMed ID: 2539569
    [Abstract] [Full Text] [Related]

  • 6. Lipid peroxidation, total antioxidant status, and total thiol levels predict overall survival in patients with oral squamous cell carcinoma.
    Patel BP, Rawal UM, Dave TK, Rawal RM, Shukla SN, Shah PM, Patel PS.
    Integr Cancer Ther; 2007 Dec; 6(4):365-72. PubMed ID: 18048884
    [Abstract] [Full Text] [Related]

  • 7. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
    Rajendran R, Remani P, Vijayakumar T, Vasudevan DM.
    Ann Dent; 1990 Dec; 49(1):36-8, 51. PubMed ID: 2346298
    [Abstract] [Full Text] [Related]

  • 8. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M, Telang S, Raval G, Shah P, Patel PS.
    Cancer; 2008 Jul 15; 113(2):336-46. PubMed ID: 18521898
    [Abstract] [Full Text] [Related]

  • 9. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
    Shukla D, Kale AD, Hallikerimath S, Yerramalla V, Subbiah V.
    J Oral Maxillofac Surg; 2013 Feb 15; 71(2):414-8. PubMed ID: 22749518
    [Abstract] [Full Text] [Related]

  • 10. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M, Nayak BR.
    Ann Dent; 1991 Feb 15; 50(2):33-5, 48. PubMed ID: 1785913
    [Abstract] [Full Text] [Related]

  • 11. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS, Rawal GN, Balar DB.
    Gynecol Oncol; 1993 Sep 15; 50(3):294-9. PubMed ID: 8406190
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Estimation and comparative study of serum total sialic acid levels as tumor markers in oral cancer and precancer.
    Joshi M, Patil R.
    J Cancer Res Ther; 2010 Sep 15; 6(3):263-6. PubMed ID: 21119250
    [Abstract] [Full Text] [Related]

  • 14. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
    Shashikanth MC, Rao BB.
    Indian J Dent Res; 1994 Sep 15; 5(4):119-24. PubMed ID: 9495093
    [Abstract] [Full Text] [Related]

  • 15. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
    Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM.
    J Oral Pathol Med; 2007 Jan 15; 36(1):25-9. PubMed ID: 17181738
    [Abstract] [Full Text] [Related]

  • 16. Serum soluble CD44v6 levels in patients with oral and maxillofacial malignancy.
    Chang SM, Xing RD, Zhang FM, Duan YQ.
    Oral Dis; 2009 Nov 15; 15(8):570-2. PubMed ID: 19563418
    [Abstract] [Full Text] [Related]

  • 17. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
    Varghese I, Sugathan CK, Balasubramoniyan G, Vijayakumar T.
    Oncology; 1987 Nov 15; 44(4):224-7. PubMed ID: 3614812
    [Abstract] [Full Text] [Related]

  • 18. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma.
    Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G.
    Eur Rev Med Pharmacol Sci; 2005 Nov 15; 9(6):361-7. PubMed ID: 16479741
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of serum glycoconjugates in precancerous and cancerous diseases of the oral cavity.
    Baxi BR, Patel PS, Adhvaryu SG, Dayal PK.
    Cancer; 1991 Jan 01; 67(1):135-40. PubMed ID: 1985709
    [Abstract] [Full Text] [Related]

  • 20. A case control study of glycoprotein status in ovarian carcinoma.
    Aranganathan S, Senthil K, Nalini N.
    Clin Biochem; 2005 Jun 01; 38(6):535-9. PubMed ID: 15885233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.